Phase 2 results at 48 weeks (Jastreboff et al., NEJM 2023): Phase 3 TRIUMPH-4 at 68 weeks (Lilly Press Release, Dec 2025): The 12 mg dose produced 28.7% body weight loss, an average of 71.2 lbs from a 248.5 lb baseline
No todos los pacientes califican para este tratamiento
Nonclinical Toxicology 13.1 Carcinogenesis, Mutagenesis, and Impairment of Fertility Carcinogenesis Carcinogenicity studies of lisdexamfetamine dimesylate have not been performed
Phentermine (Lomaira) is a stimulant that suppresses appetite
Acromegaly Kidney morphology Acromegaly is associated with renal hypertrophy in humans and rodents [1]
Injections such as Semaglutide, Tirzepatide, and lipotropics have shown promising results in both clinical studies and real-world patients